©The Author(s) 2024.
World J Transplant. Sep 18, 2024; 14(3): 96225
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.96225
Published online Sep 18, 2024. doi: 10.5500/wjt.v14.i3.96225
Table 1 Risk factors for tuberculosis in transplant candidates and recipients
| Risk factors in transplant candidates | Risk factors in transplant recipients |
| Presence of comorbidities: Diabetes mellitus, COPD | Donor-derived tuberculosis |
| Smoking | Co-existing infections: COVID-19, HIV, Nocardiosis, Pneumocystis jirovecii, CMV |
| Transplant candidate age: Young and Elderly | Induction: Anti-T-lymphocyte antibodies or OKT3 |
| Immunomodulatory states: Chronic HCV infection, CMV infection | Maintenance immunosuppression: Antiproliferative agents (MMF); Prednisolone-Azathioprine; immunosuppression; Everolimus |
| Chronic liver disease | Graft rejection: Intensification of immunosuppression |
| Dialysis vintage | Genetic factors: HLA A68(28)/A69(28) locus (in Indian sub-population) |
| Previous history of tuberculosis or TBI: Positive tuberculin test or chest X-ray; suggestive of previous infection | — |
| Family history of tuberculosis | — |
| Other co-existing infections: COVID19, HIV | — |
- Citation: Prasad P, Sharma S, Mohanasundaram S, Agarwal A, Verma H. Tuberculosis in kidney transplant candidates and recipients. World J Transplant 2024; 14(3): 96225
- URL: https://www.wjgnet.com/2220-3230/full/v14/i3/96225.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i3.96225